OBJECTIVES The aim of this study was to mechanistically investigate associations among cigarette smoking, microvascular pathology, and longer term health outcomes in patients with acute ST-segment elevation myocardial infarction (MI).
C igarette smoking is persistently common (1, 2) and causal in the pathophysiology of acute myocardial infarction (MI) (3) (4) (5) (6) ). An apparent paradoxical relationship has been described between smoking and prognosis after acute MI, with lower crude rates of adverse cardiac events reported (7) (8) (9) (10) (11) (12) . Confounders, including younger age and fewer vascular risk factors, may explain the smoker's paradox (6) (7) (8) (9) (10) (11) (12) . Moreover, the duration of follow-up in many studies was #12 months, and those studies with longer follow-up identified smoking as an adverse prognostic factor (13) (14) (15) , implying the risk may operate in the longer term post-MI.
The pathophysiology of myocardial reperfusion injury in smokers with acute
ST-segment elevation MI (STEMI) is incompletely
understood. Higher epicardial coronary flow rates after primary percutaneous coronary intervention (PCI) have been reported in current smokers versus nonsmokers (10) . Studies of smoking and microvascular pathology, using cardiac magnetic resonance (CMR), have reported conflicting results (12, 16) , specifically pertaining to myocardial hemorrhage (an independent predictor of adverse outcome post-MI) (17, 18) . The MRI method in previous studies was not specific for detecting myocardial hemorrhage, and information on health outcomes was limited to 12-month follow-up (12) or was unavailable (16) . T2* mapping has emerged as a specific technique for detecting myocardial hemorrhage post-MI (18), with potential to resolve this controversy. Further insights into the effect of smoking on myocardial reperfusion injury could be provided by invasive microcirculatory assessment in the culprit coronary artery, using index of microcirculatory resistance (IMR), which is associated with infarct size, left ventricular (LV) pathology, and health outcomes (19) (20) (21) (22) (23) (24) .
We aimed to prospectively investigate associations between smoking, microvascular pathology and longer term health outcomes in patients with acute STEMI.
We hypothesized that current smoking in patients with acute STEMI would be associated with acute microvascular dysfunction revealed by IMR and progressive hemorrhagic transformation within the infarct zone revealed by T2* MRI 2 days post-MI. We also hypothesized that smoking would be an independent predictor of adverse longer term health outcomes.
METHODS STUDY POPULATION.
We performed a prospective cohort study at a regional cardiac center from July (27) and frame count (28) were assessed at initial angiography and at the end of the procedure.
TIMI myocardial perfusion grade (29) was assessed at the end of the procedure (Supplemental Appendix). Figure 2 ). Reasons for not being enrolled are detailed in Figure 2 . Compared with nonsmokers, current smokers were younger and had fewer cardiovascular risk factors ( Table 1 ). The distribution of the infarct-related artery differed between smokers and nonsmokers, whereas the biochemical size of infarction was similar.
CULPRIT The mean absolute difference between measures was 2.83 g/m 2 , and the root mean square error was 3.51.
Bland-Altman plots showed no evidence of bias.
Baseline infarct size, MVO, and LV function were similar between groups, whereas LV mass was greater in male smokers than male nonsmokers, consistent with the age difference between the groups ( Values are mean AE SD, n (%), or median (interquartile range). The p values were obtained from Student t-tests (t), Mann-Whitney U tests (MW), or Fisher exact tests. TIMI flow grades pre-and post-PCI were grouped as 0/1 versus 2/3 for this analysis. *Diabetes mellitus was defined as a history of diet-controlled or treated diabetes.
†Killip classification of heart failure after acute myocardial infarction: class I, no heart failure; class II, pulmonary rales or crepitations, a third heart sound, and elevated jugular venous pressure; class III, acute pulmonary edema; class IV, cardiogenic shock. ‡Multivessel coronary artery disease was defined according to the number of stenoses of at least 50% of the reference vessel diameter, by visual assessment, and whether or not there was left main stem involvement. §C-reactive protein was available in 316 subjects, and troponin T was available in 313 subjects. IMR was available in 283 subjects.
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker; BMI ¼ body mass index; LAD ¼ left anterior descending coronary artery; LCx ¼ left circumflex coronary artery; LM ¼ left main coronary artery; NT-proBNP ¼ N-terminal pro-brain natriuretic peptide; PCI ¼ percutaneous coronary intervention; RCA ¼ right coronary artery; TIMI ¼ Thrombolysis In Myocardial Infarction.
hemorrhage was higher in smokers (46%) than in nonsmokers (34%), although this difference was not significant ( Table 2) . Values are mean AE SD, n (%), or median (interquartile range). Area at risk was measured using T2 mapping. The p values were obtained using Student t-tests (t), Mann-Whitney U tests (MW), or Fisher exact tests. LV ejection fraction was missing in 29 subjects at follow-up. LVEDV at follow-up was missing in 16 men and 8 women. T2* imaging for myocardial hemorrhage was available in 245 subjects.
CMR ¼ cardiac magnetic resonance; LV ¼ left ventricular; LVEDV ¼ LV end-diastolic volume; LVESV ¼ left ventricular end-systolic volume; MI ¼ myocardial infarction; T1 ¼ myocardial longitudinal relaxation time.
Despite their younger age, the longer-term prognosis of smokers is worse than that of nonsmokers, including for cardiac events. Our findings should dispel the false notion of any favorable associations between smoking and prognosis after acute STEMI.
NEW PATHOPHYSIOLOGICAL INSIGHTS INTO THE
APPARENT SMOKER'S PARADOX IN ACUTE STEMI. Consistent with prior studies (4,7-12,16), we found that smoking was crudely associated with more favorable presenting characteristics (e.g., younger age) and procedure outcomes. In contrast to prior reports (7-12), smoking was independently associated with increased risk for adverse longer term health outcomes.
Our results indicate distinct phases in the early course of MI in smokers ( Figure 3 ). We observed a reverse paradox in that smoking was associated with less reperfusion injury acutely, as revealed by angiography, electrocardiography, and invasive microcirculatory measurements using IMR, but 2 days later, myocardial hemorrhage was more pronounced (Figure 1 ), even after adjustment for confounding covariates.
We postulate the following explanations for these findings. First, smokers were younger, they had fewer risk factors for microvascular dysfunction (4,7-12), and they presented with anterior MI less often. These factors most likely explain why smokers had less reperfusion injury acutely. Given the harmful effects of smoking on vascular health (4), the reperfused microvessels in smokers may have reduced repair potential and thus greater susceptibility to progressive degradation within the infarct core in the days after reperfusion. Second, in a serial imaging study, we found that myocardial hemorrhage was preceded by MVO (18), as MVO is an upstream event that may resolve. Our results indicate that the progression to infarct zone hemorrhage, rather than recovery without hemorrhage, was more likely in smokers than nonsmokers. Even after accounting for infarct size, the association between smoking and infarct zone hemorrhage persisted, unlike for MVO. This observation is prognostically relevant because myocardial hemorrhage reflects irreversible tissue damage (17, 18) . A recent study that described the independent prognostic importance of MVO post-MI did not include information on myocardial hemorrhage (42) .
Using contemporary, multiparametric cardiac magnetic resonance using T2* mapping, we have found that myocardial hemorrhage is a much stronger determinant of adverse prognosis than MVO (18).
The lack of an association between smoking and myocardial hemorrhage in prior studies (12) may have been related to the use of dark-blood T2-weighted 
